These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aggressiveness of screen-detected breast cancers. Hakama M; Holli K; Isola J; Kallioniemi OP; Kärkkäinen A; Visakorpi T; Pukkala E; Saarenmaa I; Geiger U; Ikkala J Lancet; 1995 Jan; 345(8944):221-4. PubMed ID: 7741862 [TBL] [Abstract][Full Text] [Related]
4. Performance and effectiveness of organised breast cancer screening in Finland. Sarkeala T Acta Oncol; 2008; 47(8):1618. PubMed ID: 18759146 [No Abstract] [Full Text] [Related]
5. Breast cancer screening as public health policy in Finland. Hakama M; Elovainio L; Kajantie R; Louhivuori K Br J Cancer; 1991 Nov; 64(5):962-4. PubMed ID: 1931626 [TBL] [Abstract][Full Text] [Related]
6. [The effectiveness of breast cancer screening in Finland]. Hakama M; Pukkala E; Kallio M; Heikkilä M Duodecim; 1997; 113(21):2171-3. PubMed ID: 10892114 [No Abstract] [Full Text] [Related]
7. [Mass screening for early breast cancer]. Morimoto T; Komaki K Nihon Rinsho; 1989 May; 47(5):1006-11. PubMed ID: 2746894 [No Abstract] [Full Text] [Related]
8. [Breast cancer diagnostics. Finnish Breast Cancer Group]. Duodecim; 1999; 115(13):1426-31. PubMed ID: 11912627 [No Abstract] [Full Text] [Related]
9. Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. Anttila A; Koskela J; Hakama M J Med Screen; 2002; 9(4):153-8. PubMed ID: 12518004 [TBL] [Abstract][Full Text] [Related]
10. [Results of the first three years of mammography screening in Turku]. Klemi PJ; Parvinen I; Toikkanen S; Räsänen O; Linna M; Brasken P; Joensuu H Duodecim; 1990; 106(20):1363-7. PubMed ID: 1670568 [No Abstract] [Full Text] [Related]
12. [Recommendations of the French Society of Mammography and Breast Pathology on quality criteria in mass screening for breast cancer in France]. Rev Fr Gynecol Obstet; 1994 Oct; 89(10):510-1. PubMed ID: 7817080 [No Abstract] [Full Text] [Related]
14. Effect of screening mammography on the surgery of breast cancer in Finland: a population-based analysis during the years 1985-2004. Paajanen H; Kyhälä L; Varjo R; Rantala S Am Surg; 2006 Feb; 72(2):167-71. PubMed ID: 16536250 [TBL] [Abstract][Full Text] [Related]
15. [Mammography screening for breast cancer]. Drozdz W; Strzałka M Przegl Lek; 1998; 55(12):663-8. PubMed ID: 10354718 [TBL] [Abstract][Full Text] [Related]
16. Estimation of natural history parameters of breast cancer based on non-randomized organized screening data: subsidiary analysis of effects of inter-screening interval, sensitivity, and attendance rate on reduction of advanced cancer. Wu JC; Hakama M; Anttila A; Yen AM; Malila N; Sarkeala T; Auvinen A; Chiu SY; Chen HH Breast Cancer Res Treat; 2010 Jul; 122(2):553-66. PubMed ID: 20054645 [TBL] [Abstract][Full Text] [Related]
17. Organised mammography screening reduces breast cancer mortality: a cohort study from Finland. Sarkeala T; Heinävaara S; Anttila A Int J Cancer; 2008 Feb; 122(3):614-9. PubMed ID: 17847022 [TBL] [Abstract][Full Text] [Related]
18. [Cost-effectiveness analysis of breast cancer screening with mammography]. Iinuma T Nihon Rinsho; 2007 Jun; 65 Suppl 6():226-8. PubMed ID: 17682158 [No Abstract] [Full Text] [Related]
19. [Screening for breast cancer]. Nielsen H Ugeskr Laeger; 1996 Jun; 158(23):3330-2. PubMed ID: 8686066 [No Abstract] [Full Text] [Related]
20. The UK breast-screening programme should start at age 47 years. Sasieni P; Cuzick J Lancet; 2003 Jul; 362(9379):246-7. PubMed ID: 12885493 [No Abstract] [Full Text] [Related] [Next] [New Search]